343 related articles for article (PubMed ID: 27069063)
1. Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
Xin L; Mekle R; Fournier M; Baumann PS; Ferrari C; Alameda L; Jenni R; Lu H; Schaller B; Cuenod M; Conus P; Gruetter R; Do KQ
Schizophr Bull; 2016 Sep; 42(5):1185-96. PubMed ID: 27069063
[TBL] [Abstract][Full Text] [Related]
2. Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.
Gysin R; Kraftsik R; Boulat O; Bovet P; Conus P; Comte-Krieger E; Polari A; Steullet P; Preisig M; Teichmann T; Cuénod M; Do KQ
Antioxid Redox Signal; 2011 Oct; 15(7):2003-10. PubMed ID: 20673128
[TBL] [Abstract][Full Text] [Related]
3. Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.
Da Silva T; Hafizi S; Andreazza AC; Kiang M; Bagby RM; Navas E; Laksono I; Truong P; Gerritsen C; Prce I; Sailasuta N; Mizrahi R
Int J Neuropsychopharmacol; 2018 Apr; 21(4):311-318. PubMed ID: 29618014
[TBL] [Abstract][Full Text] [Related]
4. Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia.
Zhang Y; Catts VS; Shannon Weickert C
Aust N Z J Psychiatry; 2018 Jul; 52(7):690-698. PubMed ID: 28891319
[TBL] [Abstract][Full Text] [Related]
5. Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts.
Giangreco B; Dwir D; Klauser P; Jenni R; Golay P; Cleusix M; Baumann PS; Cuénod M; Conus P; Toni N; Do KQ
Mol Psychiatry; 2023 May; 28(5):1983-1994. PubMed ID: 37002404
[TBL] [Abstract][Full Text] [Related]
6. Chronic beryllium disease and glutathione biosynthesis genes.
Bekris LM; Viernes HM; Farin FM; Maier LA; Kavanagh TJ; Takaro TK
J Occup Environ Med; 2006 Jun; 48(6):599-606. PubMed ID: 16766924
[TBL] [Abstract][Full Text] [Related]
7. Interaction of GAG trinucleotide repeat and C-129T polymorphisms impairs expression of the glutamate-cysteine ligase catalytic subunit gene.
Butticaz C; Gysin R; Cuénod M; Do KQ
Free Radic Biol Med; 2011 Mar; 50(5):617-23. PubMed ID: 21156206
[TBL] [Abstract][Full Text] [Related]
8. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.
Gysin R; Kraftsik R; Sandell J; Bovet P; Chappuis C; Conus P; Deppen P; Preisig M; Ruiz V; Steullet P; Tosic M; Werge T; Cuénod M; Do KQ
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16621-6. PubMed ID: 17921251
[TBL] [Abstract][Full Text] [Related]
9. Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes.
Gu F; Chauhan V; Chauhan A
Free Radic Biol Med; 2013 Dec; 65():488-496. PubMed ID: 23892356
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
Conus P; Seidman LJ; Fournier M; Xin L; Cleusix M; Baumann PS; Ferrari C; Cousins A; Alameda L; Gholam-Rezaee M; Golay P; Jenni R; Woo TW; Keshavan MS; Eap CB; Wojcik J; Cuenod M; Buclin T; Gruetter R; Do KQ
Schizophr Bull; 2018 Feb; 44(2):317-327. PubMed ID: 29462456
[TBL] [Abstract][Full Text] [Related]
11. Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome.
Gysin R; Riederer IM; Cuénod M; Do KQ; Riederer BM
Brain Res Bull; 2009 Apr; 79(1):46-52. PubMed ID: 19041695
[TBL] [Abstract][Full Text] [Related]
12. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.
Dalton TP; Dieter MZ; Yang Y; Shertzer HG; Nebert DW
Biochem Biophys Res Commun; 2000 Dec; 279(2):324-9. PubMed ID: 11118286
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
Girgis RR; Baker S; Mao X; Gil R; Javitt DC; Kantrowitz JT; Gu M; Spielman DM; Ojeil N; Xu X; Abi-Dargham A; Shungu DC; Kegeles LS
Psychiatry Res; 2019 May; 275():78-85. PubMed ID: 30884334
[TBL] [Abstract][Full Text] [Related]
15. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
16. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels.
Bekris LM; Shephard C; Janer M; Graham J; McNeney B; Shin J; Zarghami M; Griffith W; Farin F; Kavanagh TJ; Lernmark A
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):221-8. PubMed ID: 17479437
[TBL] [Abstract][Full Text] [Related]
17. Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation.
Campolo J; Penco S; Bianchi E; Colombo L; Parolini M; Caruso R; Sedda V; Patrosso MC; Cighetti G; Marocchi A; Parodi O
Am Heart J; 2007 Dec; 154(6):1123-9. PubMed ID: 18035085
[TBL] [Abstract][Full Text] [Related]
18. A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers.
Nichenametla SN; Muscat JE; Liao JG; Lazarus P; Richie JP
Mol Carcinog; 2013 Oct; 52(10):791-9. PubMed ID: 22610501
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex.
Rigucci S; Xin L; Klauser P; Baumann PS; Alameda L; Cleusix M; Jenni R; Ferrari C; Pompili M; Gruetter R; Do KQ; Conus P
Psychopharmacology (Berl); 2018 Jan; 235(1):13-22. PubMed ID: 29075884
[TBL] [Abstract][Full Text] [Related]
20. Influence of glutathione-related genetic variants on the oxidative stress profile of Mexican patients with psychotic disorders.
Mayén-Lobo YG; Alcaraz-Zubeldia M; Dávila-Ortiz de Montellano DJ; Motilla-Frías BA; García-Manteca MY; Ortega-Vázquez A; Aviña-Cervantes CL; Crail-Meléndez ED; Ríos C; López-López M; Monroy-Jaramillo N
Braz J Psychiatry; 2023 May; 45(2):117-126. PubMed ID: 36318479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
